Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-042-5 | CAS number: 10025-78-2
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene mutation (Bacterial reverse mutation assay / Ames test): negative with and without activation in Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 or TA 1538 (similar to OECD Test Guideline 471 with restrictions such as only 4 doses were tested and not in duplicates; the range of strains does not comply with current guidelines; the study was conducted in compliance with GLP) (Dow Corning Corporation, 1981).
Gene mutation (Bacterial reverse mutation assay / Ames test): read-across from analogous substance trimethoxysilane (CAS 2487-90-3); negative with and without activation in Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and E. coli WP2 uvrA (OECD Test Guideline 471 and in compliance with GLP) (Microbiological Associates, 1995).
Cytogenicity in mammalian cells: read-across from analogous substance trimethoxysilane (CAS 2487-90-3); positive for induction of structural chromosome abnormalities with activation in CHO cells (OECD Test Guideline 473 and in compliance with GLP) (BioReliance, 2007).
Mutagenicity in mammalian cells: read-across from analogous substance triethoxysilane (CAS 998-30-1); negative in L5178Y mouse lymphoma cells (similar to OECD Test Guideline 476 and in compliance with GLP) (Dow Corning Corporation, 1995).
Link to relevant study records
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2006-08-16 to 2006-09-17
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor induced rat liver S9
- Test concentrations with justification for top dose:
- 152.5 to 1220 µg/ml
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: solubility of the test article and compatibility with target cells. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- mitomycin C
- Remarks:
- (without activation)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- (with activation)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: 16 - 24 hours
- Exposure duration: 4 - 20 hours (-MA), 4 hours (+MA)
NUMBER OF REPLICATIONS: 2 flasks per concentration
DETERMINATION OF CYTOTOXICITY
- Method: Cell growth inhibition relative to the solvent control
- Evaluation criteria:
- Toxicity based on cell growth inhibition relative to solvent control.
The number and types of aberrations found, % aberrant cells in the total population of cells examined, and mean aberrations per cell were calculated and reported for each treatment group.
The test article was considered to induce a positive response when the percentage of cells with aberrations is increased in a dose-responsive manner with one or more concentrations being statistically significant (p≤0.05). - Statistics:
- Fisher's exact test was used to compare pairwise the percent aberrant cells of each treatment group with that of the solvent control. In the event of a positive Fisher's Exact test at any test article dose level, the Cochran-Armitage test was used to measure dose-responsiveness.
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with
- Genotoxicity:
- other: positive structural, negative numerical
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- 1220 µg/ml (4 hour group)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- 1220 µg/ml (4 hour group)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Conclusions:
- Trimethoxysilane (CAS 2487-90-3) has been tested in a reliable in vitro mammalian cytogenicity study, conducted according to OECD Test Guideline 473 and in compliance with GLP. Trimethoxysilane was concluded to be positive for the induction of structural and negative for the induction of numerical chromosome aberrations in CHO cells in the presence of metabolic activation system at the highest dose tested. No chromosomal aberrations were noted when tested in the absence of metabolic activation. Appropriate solvent and positive controls were included and gave the expected results. It is concluded that trimethoxysilane is positive for the induction of chromosome aberrations in vitro under the conditions of the test.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 08-04-1994
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- TK Locus
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Fischer's Medium for Leukemic Cells of Mice with 0.1 % Pluronics, supplemented with 10 % horse serum and 4 mM L-glutamine.
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- Cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254.
- Test concentrations with justification for top dose:
- 313, 625, 1250, 2500 and 5000 µg/ml
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Ethanol.
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 7,12-dimethylbenzanthracene
- Remarks:
- + S9: 5.0 and 2.5 µl/ml in ethanol.
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- -S9: 0.5 and 0.25 µl/ml in ethanol.
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium.
DURATION
- Exposure duration: 4 hours.
- Expression time (cells in growth medium): 2 days
- Selection time (if incubation with a selection agent): 10-12 days.
SELECTION AGENT (mutation assays): 3 µg/ml trifluorothymidine (TFT)
NUMBER OF REPLICATIONS: 2
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency and relative total growth.
OTHER: Small and large colonies were differentiated, as small colonies are capable to indicate chromosomal mutations.
Cofactors: 11.25 mg DL-Isocitric acid and 6.0 mg nicotinamide adenine dinucleotide phosphate (NADP), pH 7.0.
Metabolic activation: Adult male Sprague-Dawley rats were induced by a single intraperitoneal injection of Aroclor-1254 at a dosage of 500 mg/kg body weight five days prior to sacrifice. - Evaluation criteria:
- In evaluation of the data, increases in mutant frequencies which occurred only at highly toxic concentrations (i.e., less than 10% total growth) were not considered biologically relevant. All conclusions were based on sound scientific judgement; however, as a guide to interpretation of the data, the test article was considered to induce a positive response if a concentration- related increase in mutant frequency was observed and more than one dose level was 10% or greater total growth exhibited a mutant frequency two-fold greater than the solvent control. A doubling above background at one or more dose levels with 10% or greater total growth with no evidence of a dose-response was considered to be equivocal. Test articles not producing a doubling above background at one or more dose levels with 10 % or greater growth was concluded to be negative.
- Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- > 2500 µg/ml
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES: The preliminary toxicity test conducted on triethoxysilane indicated 94% toxicity at 5000 µg/ml for the non-activated cultures and 65% toxicity at 5000 µg/ml for the S-9 activated cultures. The cultures treated with 140 µl of ethanol exhibited average suspension growths of 91% of control in the absence of S-9 and 87 % of control in the presence of S-9. The osmolality of the solvent control was 457 mOsm (530 mOsm/kg for 140 µl ethanol) and the osmolality of the top dose, 5000 µg/ml, was 463 mOsm/kg. Based on the results of the initial toxicity test, the doses chosen for the mutagenesis assay ranged from 5000 to 39 µg/ml for both the non-activated cultures and for the S-9 activated cultures.
- Conclusions:
- Triethoxysilane (CAS 998-30-1) has been tested in a reliable in vitro mammalian mutagenicity assay with the structural analogue, conducted according to OECD Test Guideline 476 and in compliance with GLP. Triethoxysilane was tested for mutagenicity in mouse lymphoma L5178Y cells. No test substance-related increase in mutant frequency was observed with or without metabolic activation when tested up to limit concentrations. Appropriate solvent and positive controls were included and gave expected results. It is concluded that triethoxysilane is negative for mutagenicity to mammalian cells under the conditions of the test.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 1981-03-10
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- only 4 doses no duplicates; the range of strains does not comply with current guidelines.
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- bacteria, other: S. typhimurium TA 1535, TA 1537, TA 1538, TA 98 and TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor induced rat liver S9
- Test concentrations with justification for top dose:
- 0.5, 5, 100 and 500 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: ethanol
- Justification for choice of solvent/vehicle: none given - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- ethanol
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- without activation: strain TA 1537
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- without activation: strains TA 98 and TA 1538
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-anthramine
- Remarks:
- all strains with activation
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- ethanol
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- without activation: TA 1535 and TA 100
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48-72 hours
- Expression time (cells in growth medium): 48-72 hours
- Fixation time (start of exposure up to fixation or harvest of cells): 48-72 hours
NUMBER OF REPLICATIONS: One
DETERMINATION OF CYTOTOXICITY
- Method: reduction in number of revertants (reviewers assessment) - Evaluation criteria:
- A reproducible dose-responsive increase in the number of revertants over 3 concentrations to at least twice the solvent control (TA 1535, 1537, 1538) or an increase over 3 concentrations with the highest increase twice the solvent control is considered positive.
- Statistics:
- The number of colonies was counted using a Model C111 Automated colony counter. Each count is listed as the average of 10 replicate counts on each plate.
- Key result
- Species / strain:
- bacteria, other: S. typhimurium TA 1535, TA 1537, TA 1538, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Other confounding effects: hydrolysis of test compound may have occurred. This is not considered by the reviewer to affect the relevance of the result.
RANGE-FINDING/SCREENING STUDIES: No information
COMPARISON WITH HISTORICAL CONTROL DATA: Historical control data not presented in study report
- Conclusions:
- Trichlorosilane has been tested in a reliable in vitro bacterial mutagenicity study, conducted according to a protocol similar to OECD Test Guideline 471 and in compliance with GLP. Trichlorosilane did not cause any test substance-related increase in the number of revertants when tested up to limit concentration in Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 or TA 1538, with and without metabolic activation. Appropriate solvent and positive controls were included and gave expected results. The substance is considered to be non-mutagenic under the conditions of the test.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9 homogenate
- Test concentrations with justification for top dose:
- 100, 333, 1000, 3333, and 5000 μg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: the solvent was chosen based on solubility of the test article and compatibility with the target cells. - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- TA 98 (without activation)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- TA 100, TA 1535 (without activation)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- TA 1537 (without activation)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- WP2, WP2uvrA (without activation)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-Aminoanthracene
- Remarks:
- All strains (with activation)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Sterigmatocystin
- Remarks:
- All strains (with activation)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); preincubation
DURATION
- Preincubation period: 60 minutes
- Expression time (cells in growth medium): 48 to 72 hours
NUMBER OF REPLICATIONS: 2 plates per test concentration
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth; background lawn assessment - Evaluation criteria:
- The test article is evaluated as positive when it causes a dose-related increase in mean revertants per plate of at least one tester strain with a minimum of two increasing concentrations of test article.
- Statistics:
- Positive controls and tester strains with revertant counts greater than 100 were counted with a colony counter (Mini Count) and those less than 100 were counted manually.
- Key result
- Species / strain:
- other: Salmonella typhimurium TA 98, TA 100, TA 1535, TA 1537; Escherichia coli WP2 and WP2 uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- > 5000 μg/plate
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: none recorded
- Effects of osmolality: none recorded
- Evaporation from medium: not reported
- Precipitation: Slight precipitation at higher concentrations did not affect assay
- Other confounding effect: In first two tests, a variation in the precipitation pattern was observed, so the tests were repeated. The findings from the initial two experiments are not recorded.
RANGE-FINDING/SCREENING STUDIES:
No toxicity observed
COMPARISON WITH HISTORICAL CONTROL DATA:
The results of the controls lie within the range of the historical control data. - Conclusions:
- Trimethoxysilane (CAS 2487-90-3) has been tested in a reliable in vitro bacterial mutagenicity study with, conducted according to OECD Test Guideline 471 and in compliance with GLP. Trimethoxysilane did not cause any increase in the number of revertants when tested up to limit concentration in Salmonella typhimurium TA 98, TA 100, TA 1535, TA 1537; Escherichia coli WP2 and WP2 uvrA, with or without metabolic activation. Appropriate solvent and positive controls were included and gave expected results. It is concluded that the test substance is negative for mutagenicity to bacteria under the conditions of the study.
Referenceopen allclose all
Table 1: Preliminary toxicity test using Trimethoxysilane in CHO cells with and without S9 metabolic activation (4 hour treatment / 16 hour recovery)
|
- MA |
+ MA |
- MA |
||||||
|
4 hour treatment / 16 hour recovery |
20 hour continuous treatment) |
|||||||
Treatment μg/ml |
Cell Viability (%) |
Cell Growth Index (%) * |
Cell Growth Inhibition (%) ** |
Cell Viability (%) |
Cell Growth Index (%) * |
Cell Growth Inhibition (%) ** |
Cell Viability (%) |
Cell Growth Index (%) * |
Cell Growth Inhibition (%) ** |
DMSO |
98 |
100 |
- |
98 |
100 |
- |
100 |
100 |
- |
0.122 |
99 |
95 |
5 |
100 |
89 |
11 |
99 |
86 |
14 |
0.366 |
99 |
79 |
21 |
100 |
96 |
4 |
99 |
92 |
8 |
1.22 |
100 |
82 |
18 |
97 |
97 |
3 |
100 |
85 |
15 |
3.66 |
97 |
76 |
24 |
99 |
80 |
20 |
97 |
87 |
13 |
12.2 |
99 |
78 |
22 |
97 |
81 |
19 |
95 |
86 |
14 |
36.6 |
98 |
67 |
33 |
98 |
86 |
14 |
96 |
99 |
1 |
122 |
98 |
63 |
37 |
100 |
98 |
2 |
97 |
94 |
6 |
366 |
99 |
68 |
32 |
99 |
78 |
22 |
98 |
87 |
13 |
1220 |
93 |
41 |
59 |
95 |
42 |
58 |
91 |
67 |
33 |
* Cell Growth Index = (cells per flask treated group/cells per flask control group), expressed as a percentage
** Cell Growth Inhibition = 100 % - % cell growth index; not calculated for negative controls
Table 2: Cytogenetic analysis of CHO cells in the absence of metabolic activation (4 hour treatment, 16 hour recovery period)
|
Control* |
152.5 μg/ml |
305 μg/ml |
610 μg/ml |
Positive control |
||||||
Flask |
A |
B |
A |
B |
A |
B |
A |
B |
A |
B |
|
Cytotoxicity |
no |
no |
no |
no |
no |
no |
yes |
yes |
no |
no |
|
Chromatid aberrations*** |
Breaks |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
10 |
7 |
Interchanges |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
|
Chromosome aberrations*** |
Gaps** |
0 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
Breaks |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Dicentric |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Rings |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
% aberrant cells |
Numerical |
2 |
3 |
5 |
5 |
4 |
5 |
3 |
3 |
1 |
2 |
Structural |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
28 |
24 |
|
Mitotic index |
|
11.0 |
11.4 |
10.8 |
10.4 |
10.0 |
10.4 |
9.6 |
8.8 |
7.4 |
6.8 |
* Solvent control with DMSO
** Total gaps
*** Total number of aberrations
Mitotic Index = number of mitotic figures x 100/500 cells counted
% Aberrant Cells: numerical cells include polyploid and endoreduplicated cells; structural cells exclude cells with only gaps
Table 3: Cytogenetic analysis of CHO cells in the presence of metabolic activation (4 hour treatment, 16 hour recovery period)
|
Control* |
152.5 μg/ml |
305 μg/ml |
1220 μg/ml |
Positive control |
||||||
Flask |
A |
B |
A |
B |
A |
B |
A |
B |
A |
B |
|
Cytotoxicity |
no |
no |
no |
no |
no |
no |
yes |
yes |
yes |
yes |
|
Chromatid aberrations*** |
Breaks |
0 |
0 |
0 |
1 |
0 |
2 |
1 |
8 |
2 |
7 |
Interchanges |
0 |
0 |
1 |
1 |
3 |
1 |
7 |
4 |
8 |
6 |
|
Chromosome aberrations*** |
Gaps** |
1 |
0 |
1 |
0 |
2 |
0 |
2 |
3 |
0 |
1 |
Breaks |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Dicentric |
0 |
1 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
0 |
|
Rings |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
1 |
|
% aberrant cells |
Numerical |
5 |
4 |
5 |
5 |
5 |
4 |
3 |
4 |
5 |
4 |
Structural |
0 |
1 |
1 |
2 |
3 |
3 |
8 |
9 |
16 |
18 |
|
Mitotic index |
|
11.6 |
11.6 |
11.2 |
11.4 |
10.6 |
11.2 |
5.4 |
6.4 |
4.0 |
3.8 |
* Solvent control with DMSO
** Total gaps
*** Total number of aberrations
Mitotic Index = number of mitotic figures x 100/500 cells counted
% Aberrant Cells: numerical cells include polyploid and endoreduplicated cells; structural cells exclude cells with only gaps
Table 4: Cytogenetic analysis of CHO cells in the absence of metabolic activation (20 hour continuous treatment
|
Control* |
152.5 μg/ml |
305 μg/ml |
610 μg/ml |
Positive control |
||||||
Flask |
A |
B |
A |
B |
A |
B |
A |
B |
A |
B |
|
Cytotoxicity |
no |
no |
no |
no |
no |
no |
yes |
yes |
no |
no |
|
Chromatid aberrations*** |
Breaks |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
4 |
3 |
Interchanges |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
3 |
|
Chromosome aberrations*** |
Gaps** |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
0 |
Breaks |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Dicentric |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Rings |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
% aberrant cells
|
Numerical |
3 |
4 |
4 |
4 |
4 |
3 |
4 |
4 |
4 |
3 |
Structural |
0 |
0 |
0 |
0 |
0 |
1 |
0 |
0 |
24 |
20 |
|
Mitotic index |
|
10.4 |
10.0 |
10.2 |
10.4 |
9.4 |
10.0 |
5.2 |
4.8 |
6.6 |
6.0 |
* Solvent control with DMSO
** Total gaps
*** Total number of aberrations
Mitotic Index = number of mitotic figures x 100/500 cells counted
% Aberrant Cells: numerical cells include polyploid and endoreduplicated cells; structural cells exclude cells with only gaps
Table 1. Total compound toxicity data in the absence of exogenous metabolic activation (-S9):
Concentration |
Cloning efficiency [%] |
Relative Total Growth [%] |
Mutants per 1E+06 cells |
Mutation factor |
-S9 |
||||
5000 A |
79 |
8 |
44 |
11 |
5000 B |
81 |
18 |
52 |
19 |
2500 A |
85 |
30 |
42 |
9 |
2500 B |
88 |
16 |
41 |
8 |
1250 A |
91 |
62 |
30 |
-3 |
1250 B |
84 |
53 |
34 |
1 |
625 A |
90 |
79 |
34 |
1 |
625 B |
72 |
71 |
42 |
9 |
313 A |
68 |
61 |
48 |
15 |
313 B |
92 |
87 |
35 |
2 |
140 µl Ethanol |
100 |
98 |
31 |
-2 |
140 µl Ethanol |
91 |
83 |
41 |
8 |
Ethanol 1 |
|
|
29 |
|
Ethanol 2 |
|
|
23 |
|
Ethanol 3 |
|
|
49 |
|
Ethanol 4 |
|
|
32 |
|
Ethyl Methanesulfonate (µl/ml)
|
|
|
|
|
0.50 |
43 |
23 |
1206 |
1164 |
0.25 |
64 |
47 |
602 |
560 |
Solvent 1 |
|
|
41 |
|
Solvent 2 |
|
|
42 |
|
Table 2. Total compound toxicity data in the presence of exogenous metabolic activation (+S9):
Concentration |
Cloning efficiency [%] |
Relative Total Growth [%] |
Mutants per 1E+06 cells |
Mutation factor |
+ S9 |
||||
5000 A |
77 |
17 |
85 |
35 |
5000 B |
95 |
36 |
51 |
1 |
2500 A |
85 |
43 |
67 |
17 |
2500 B |
85 |
47 |
53 |
3 |
1250 A |
106 |
101 |
48 |
-2 |
1250 B |
95 |
84 |
42 |
-8 |
625 A |
95 |
98 |
51 |
1 |
625 B |
113 |
120 |
42 |
-8 |
313 A |
102 |
114 |
46 |
-4 |
313 B |
115 |
120 |
49 |
-1 |
140 µl Ethanol |
104 |
103 |
45 |
-5 |
140 µl Ethanol |
94 |
92 |
63 |
13 |
Ethanol 1 |
|
|
62 |
|
Ethanol 2 |
|
|
45 |
|
Ethanol 3 |
|
|
43 |
|
Ethanol 4 |
|
|
49 |
|
Ethyl Methanesulfonate (µl/ml)
|
|
|
|
|
0.50 |
35 |
35 |
417 |
360 |
0.25 |
71 |
71 |
179 |
132 |
Solvent 1 |
|
|
40 |
|
Solvent 2 |
|
|
54 |
|
Table 1a: Experiment 1 Plate incorporation Number of revertants per plate (mean of 3 plates)
TA98 |
TA100 |
TA1535 |
|||||||
Conc. |
- MA |
+ MA |
Cytotoxic |
- MA |
+ MA |
Cytotoxic |
- MA |
+ MA |
Cytotoxic |
0* |
16 |
30 |
no |
325 |
287 |
no |
14 |
14 |
no |
0.5 |
15 |
26 |
no |
281 |
262 |
no |
17 |
17 |
no |
5 |
14 |
32 |
no |
226 |
291 |
no |
14 |
16 |
no |
100 |
11 |
18 |
no |
245 |
268 |
no |
10 |
20 |
no |
500 |
11 |
28 |
no |
281 |
233 |
no |
5 |
14 |
yes |
Positive control |
>1000 |
>1000 |
no data |
>1000 |
>1000 |
no data |
1000 |
62 |
no data |
*solvent control withethanol
Table 1b: Experiment 1 Plate incorporation Number of revertants per plate (mean of 3 plates)
TA1537 |
TA1538 |
|||||
Conc. |
- MA |
+ MA |
Cytotoxic |
- MA |
+ MA |
Cytotoxic |
0* |
11 |
6 |
no |
4 |
24 |
no |
0.5 |
8 |
4 |
no |
3 |
24 |
no |
5 |
12 |
7 |
no |
1 |
23 |
no |
100 |
12 |
5 |
no |
2 |
10 |
yes |
500 |
2 |
7 |
yes |
4 |
7 |
yes |
Positive control |
44 |
22 |
no data |
>1000 |
316 |
no data |
*solvent control with ethanol
Table 1 Preliminary toxicity test
|
TA 100 |
WP2 uvrA (pKM101) |
||||
Concentration (μg/Plate) |
Plate 1 + MA |
Plate 2 - MA |
Cytotoxic (Yes/No) |
Plate 1 + MA |
Plate 2 - MA |
Cytotoxic (Yes/No) |
0 |
199 |
174 |
no |
250 |
208 |
no |
6.7 |
180 |
173 |
no |
234 |
187 |
no |
10 |
165 |
157 |
no |
241 |
210 |
no |
33 |
174 |
163 |
no |
200 |
198 |
no |
67 |
179 |
197 |
no |
228 |
185 |
no |
100 |
196 |
152 |
no |
195 |
217 |
no |
333 |
177 |
170 |
no |
186 |
184 |
no |
667 |
175 |
175 |
no SP |
230 |
214 |
no SP |
1000 |
169 |
156 |
no SP |
138 |
168 |
no SP |
3333 |
199 |
174 |
no SP |
221 |
169 |
no SP |
5000 |
174 |
158 |
no SP |
247 |
180 |
no SP |
SP Slight precipitate
Table 2: Experiment 1 Plate incorporation assayNumber of revertants per plate (mean of 3 plates)
|
TA98 |
TA100 |
TA1535 |
||||||
Conc. |
-MA |
+ MA |
Cytotoxic |
- MA |
+ MA |
Cytotoxic |
- MA |
+ MA |
Cytotoxic |
0* |
13 |
17 |
no |
95 |
144 |
no |
10 |
11 |
no |
100 |
13 |
17 |
no |
89 |
127 |
no |
9 |
11 |
no |
333 |
13 |
18 |
no |
86 |
135 |
no |
8 |
11 |
no |
1000 |
14 |
16 |
no |
85 |
116 |
no |
9 |
11 |
no |
3333 |
17 |
21 |
no |
97 |
116 |
no |
6 |
14 |
no |
5000 |
13 |
21 |
no |
95 |
111 |
no |
7 |
13 |
no |
Positive Control |
1304 |
1050 |
- |
581 |
997 |
- |
497 |
124 |
- |
*solvent control with DMSO
Table 2: Experiment 1 Plate incorporation assayNumber of revertants per plate (mean of 3 plates)
|
TA1537 |
WP2 uvrA (pKM101) |
WP2 (pKM101) |
||||||
Conc. |
-MA |
+ MA |
Cytotoxic |
- MA |
+ MA |
Cytotoxic |
- MA |
+ MA |
Cytotoxic |
0* |
4 |
6 |
no |
226 |
263 |
no |
65 |
64 |
no |
100 |
4 |
10 |
no |
236 |
295 |
no |
54 |
64 |
no |
333 |
3 |
5 |
no |
239 |
258 |
no |
87 |
60 |
no |
1000 |
6 |
8 |
no |
210 |
294 |
no |
62 |
53 |
no |
3333 |
5 |
8 |
no |
213 |
273 |
no |
67 |
64 |
no |
5000 |
5 |
6 |
no |
197 |
247 |
no |
67 |
61 |
no |
Positive Control |
215 |
130 |
- |
1554 |
1262 |
- |
1476 |
499 |
- |
*solvent control withDMSO
Table 3: Experiment 2 Pre incubation assayNumber of revertants per plate (mean of 3 plates)
|
TA98 |
TA100 |
TA1535 |
||||||
Conc. |
— MA |
+ MA |
Cytotoxic |
— MA |
+ MA |
Cytotoxic |
— MA |
+ MA |
Cytotoxic |
0* |
15 |
24 |
no |
102 |
129 |
no |
11 |
10 |
no |
50 |
26 |
24 |
no |
112 |
122 |
no |
10 |
11 |
no |
160 |
21 |
20 |
no |
105 |
116 |
no |
11 |
9 |
no |
500 |
24 |
14 |
no |
101 |
120 |
no |
12 |
10 |
no |
1600 |
23 |
17 |
no |
110 |
128 |
no |
9 |
12 |
no |
5000 |
19 |
18 |
no |
100 |
123 |
no |
10 |
11 |
no |
Positive Control |
764 |
909 |
- |
527 |
902 |
- |
433 |
117 |
- |
*solvent control with DMSO
Table 3: Experiment 2 Pre incubation assayNumber of revertants per plate (mean of 3 plates)
|
TA1537 |
WP2 uvrA (pKM101) |
WP2 (pKM101) |
||||||
Conc. |
-MA |
+ MA |
Cytotoxic |
- MA |
+ MA |
Cytotoxic |
- MA |
+ MA |
Cytotoxic |
0* |
5 |
7 |
no |
204 |
334 |
no |
23 |
21 |
no |
100 |
5 |
5 |
no |
274 |
278 |
no |
25 |
21 |
no |
333 |
5 |
5 |
no |
173 |
316 |
no |
26 |
25 |
no |
1000 |
5 |
6 |
no |
208 |
296 |
no |
26 |
22 |
no |
3333 |
5 |
4 |
no |
206 |
285 |
no |
31 |
28 |
no |
5000 |
5 |
6 |
no |
214 |
283 |
no |
28 |
24 |
no |
Positive Control |
250 |
119 |
- |
2225 |
1304 |
- |
358 |
1222 |
- |
*solvent control withDMSO
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Genetic toxicity in vivo
Description of key information
Micronucleus assay inhalation study in rat: read-across from analogous substance trimethoxysilane (CAS 2487-90-3); Negative (similar to OECD Test Guideline 474 and in compliance with GLP) (Dow Corning Corporation, 1982).
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1982-04-21 to 1982-05-14
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- only 1000 cells scored (compared to 2000 in the guideline).
- Principles of method if other than guideline:
- Micronucleus test in vivo: Matter and Schmid, 1971, Mut. Res. 12: 417-425.
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Spartan Research Laboratories, Inc. Harlet, MI
- Weight at study initiation: 100 to 175 grams
- Housing: Animals housed individually
- Diet: PURINA Rodent Laboratory Chow, ad libitum
- Water: ad libitum - Route of administration:
- inhalation
- Vehicle:
- - Vehicle(s)/solvent(s) used: air
- Concentration of test material in vehicle: 100 ppm - Details on exposure:
- TYPE OF INHALATION EXPOSURE: nose only
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: specially constructed glass chamber
- System of generating particulates/aerosols: vapours were generated by bubbling clean, dry air through the liquid test material - Duration of treatment / exposure:
- 4 hour(s)
- Frequency of treatment:
- Single 4 hour exposure
- Post exposure period:
- 30 hours
- Dose / conc.:
- 100 ppm (nominal)
- No. of animals per sex per dose:
- 5 animals per dose level
- Control animals:
- yes, concurrent no treatment
- Positive control(s):
- triethylenemelamine
- Route of administration: split-dose intraperitoneal injection (0 and 24 hours)
- Doses / concentrations: 0.5 mg/kg/dose - Tissues and cell types examined:
- Animals were exposed to the test article by acute inhalation. They were sacrificed, the bone marrow is extracted and smear preparations made and stained. Polychromatic erythrocytes are scored for micronuclei under the microscope. Both positive and negative (solvent) controls are used in each experiment.
- Details of tissue and slide preparation:
- At sacrifice the adhering soft tissue and epiphyses of both tibiae were removed. The marrow was aspirated from the bone and transferred to centrifuge tubes containing 5 ml fetal calf serum (one tube for each animal). Following centrifugation to pellet the tissue, the supernatant was drawn off and portions of the pellet was spread on slides and air-dried. The slides were then stained in May-Gruenwald Solution and Giemsa. A thousand polychromatic erythrocytes (PCEs) per animal were scored. The frequency of micronucleated was expressed as percent micronucleated cells based on the total PCEs present in the scored optic field.
- Evaluation criteria:
- In the normal animal, the normocytes/PCE's is approximately 2. If an agent inhibits the proliferation of erythroblasts the proportion of PCE's is generally reduced. If the agent promotes chromosome breakage or acts as a spindle poison, generally the proportion of red normocytes increases.
- Statistics:
- Mean normocyte and polychromatic erythrocytes calculated as well as ratio of normocytes to PCE's. Student T-test was used to confirm no difference between the PCE MN count for study groups A(treated) and D(control).
- Key result
- Sex:
- female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 100 ppm
- Clinical signs of toxicity in test animals: To ensure that the Micronucleus Assay was performed on animals exposed to a lethal concentration of the test material (Group A), a second group of animals (Group B) was simultaneously exposed to the chemical via inhalation as a positive control for lethality. The data demonstrates that both groups (A&B) was exposed to a lethal concentration of the test material. All five animals in Group B experienced weight loss and died within the 14 day observation period. At autopsy all five animals showed extensive lung damage with haemorrhage and atelectasis. Animals exposed via inhalation to the test material all showed slight to moderate evidence of lung damage in the form of petechial haemorrhage and focal atelectasis. Some evidence of kidney congestion was noted in several animals. No abnormal pathology was evident in either the positive control (C) or negative control (D) groups.
- Evidence of cytotoxicity in tissue analysed: The ratio of normocytes to PCE's obtained with both the test material treatment (Group A = 10.64) and the negative control (Group D = 10.28) closely approximate the normal expected ratio and were fairly consistent. The mean normocyte count from the positive control group was elevated (Group C = 19.4) indicating that the animals responded to a known clastogen (chromosome breaking agent). This same trend verified by the increase in percentage of micronucleated PCEs in the positive control group.
- Harvest times: Group A (Treatment group): 30 hours after exposure. Group C (Positive Control): 30 hours. Group D (Negative Control): 30 hours.
- High dose: 100 ppm
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): Within normal range for all groups
- Ratio of PCE/NCE (for Micronucleus assay): Within normal range for all groups
- Statistical evaluation: Comparison of the study groups by Student T-test using a SAS computer program confirms there is no difference between the mean PCE micronucleus count for study groups A and D (test article and negative control) (<.0001) while the positive control is definitely positive (p>0.5) compared to the former groups. - Conclusions:
- Trimethoxysilane (CAS 2487-90-3) has been tested in a reliable in vivo mammalian micronucleus assay, conducted according to a protocol similar to OECD Test Guideline 474 and in compliance with GLP. Trimethoxysilane did not induce chromosome breakage or act as a spindle poison in the rodent micronucleus assay even when animals were exposed to lethal concentrations. There is no evidence from this study that mortality involves genotoxicity. In conclusion, trimethoxysilane is concluded to be non-mutagenic in Sprague-Dawley rats.
Reference
The following table indicates that the animals responded to the positivecontrol substance. Both normocytes/PCE **
ratio and % of micronucleated PCEs weresignificantly increased in the positive control group when compared to test material-treated group.
Table 3 : Mean Results of in vivo micronucleus test with mouse bone marrow
|
Test Group (A) |
Positive Control (C) |
Negative Control (D) |
|
Number of cells evaluated |
1000 |
1000 |
1000 |
|
Sampling time (h) |
30h |
30h |
30h |
|
Number of erythrocytes |
Normocytes / Field |
10.64 |
19.4 |
10.28 |
PCE / Field |
4.36 |
4.56 |
4.36 |
|
Micronuclei / 1000 PCE |
6.8 |
39.2 |
5.6 |
|
Ratio of erythrocytes |
Normochromatic / polychromatic |
2.52 |
4.38 |
2.39 |
% Micronucleated PCE |
0.68 |
3.92 |
0.56 |
|
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Information is available from a reliable bacterial mutagenicity study for trichlorosilane (CAS 10025-78-2). No further data are available for the registered substance, however, reliable data are available for the structural analogue substances trimethoxysilane (CAS 2487-90-3) and triethoxysilane (CAS 998-30-1). A bacterial mutagenicity study, an in vitro chromosome aberration assay in mammalian cells and an in vivo micronucleus assay is available for the structural analogue substance trimethoxysilane (CAS 2487-90-3). An in vitro mutagenicity study in mammalian cells is available for triethoxysilane (CAS 998-30-1). See attachment to Section 13 for justification of read-across.
The registered substance trichlorosilane has been tested in a reliable in vitro bacterial mutagenicity study, conducted according to a protocol similar to OECD Test Guideline 471 with deviations and in compliance with GLP. The restrictions include that only 4 doses were tested, duplicate cultures were not used, the range of strains does not comply with current guideline requirements. Trichlorosilane did not cause any test substance-related increase in the number of revertants when tested up to limit concentration in Salmonella typhimurium strains TA98, TA100, TA1535, TA1537 or TA 1538, with and without metabolic activation. Appropriate solvent and positive controls were included and gave expected results. The substance is considered to be non-mutagenic under the conditions of the test (Dow Corning Corporates, 1981).
The structural analogue trimethoxysilane (CAS 2487-90-3) has been tested in a reliable in vitro bacterial mutagenicity study with, conducted according to OECD Test Guideline 471 and in compliance with GLP. Trimethoxysilane did not cause any increase in the number of revertants when tested up to limit concentration in Salmonella typhimurium TA 98, TA 100, TA 1535, TA 1537; Escherichia coli WP2 and WP2 uvrA, with or without metabolic activation. Appropriate solvent and positive controls were included and gave expected results. It is concluded that the test substance is negative for mutagenicity to bacteria under the conditions of the study (Microbiological Associates, 1995).
The structural analogue trimethoxysilane (CAS 2487-90-3) has been tested in a reliable in vitro mammalian cytogenicity study, conducted according to OECD Test Guideline 473 and in compliance with GLP. Trimethoxysilane was concluded to be positive for the induction of structural and negative for the induction of numerical chromosome aberrations in CHO cells in the presence of metabolic activation system at the highest dose tested. No chromosomal aberrations were noted when tested in the absence of metabolic activation. Appropriate solvent and positive controls were included and gave the expected results. It is concluded that trimethoxysilane is positive for the induction of chromosome aberrations in vitro under the conditions of the test (BioReliance, 2007).
The structural analogue triethoxysilane (CAS 998-30-1) has been tested in a reliable in vitro mammalian mutagenicity assay with the structural analogue, conducted according to OECD Test Guideline 476 and in compliance with GLP. Triethoxysilane was tested for mutagenicity in mouse lymphoma L5178Y cells. No test substance-related increase in mutant frequency was observed with or without metabolic activation when tested up to limit concentrations. Appropriate solvent and positive controls were included and gave expected results. It is concluded that triethoxysilane is negative for mutagenicity to mammalian cells under the conditions of the test (Dow Corning Corporation, 1995).
The structural analogue trimethoxysilane (CAS 2487-90-3) has been tested in a reliable in vivo mammalian micronucleus assay, conducted according to a protocol similar to OECD Test Guideline 474 and in compliance with GLP. Trimethoxysilane did not induce chromosome breakage or act as a spindle poison in the rodent micronucleus assay even when animals were exposed to lethal concentrations. There is no evidence from this study that mortality involves genotoxicity. In conclusion, trimethoxysilane is concluded to be non-mutagenic in Sprague-Dawley rats (Dow Corning Corporation, 1982).
Justification for classification or non-classification
Based on the available in vitro and in vivo genotoxicity data, trichlorosilane is not classified for mutagenicity according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
